iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$4.85M
Expense Ratio	0.47%
PE Ratio	16.48
Shares Out	150,000
Dividend (ttm)	$0.32
Dividend Yield	1.02%
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Annual
Payout Ratio	16.58%

Volume	920
Open	32.12
Previous Close	31.32
Day's Range	31.40 - 32.12
52-Week Low	17.86
52-Week High	33.32
Beta	0.72
Holdings	72
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

40.70% of assets

Name	Symbol	Weight
Axsome Therapeutics, Inc.	AXSM	4.87%
Praxis Precision Medicines, Inc.	PRAX	4.69%
PTC Therapeutics, Inc.	PTCT	4.04%
Xenon Pharmaceuticals Inc.	XENE	4.02%
Biogen Inc.	BIIB	3.98%
ACADIA Pharmaceuticals Inc.	ACAD	3.89%
Alkermes plc	ALKS	3.89%
Scholar Rock Holding Corporation	SRRK	3.86%
argenx SE	ARGX	3.79%
Neurocrine Biosciences, Inc.	NBIX	3.67%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.31981	Dec 19, 2025
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023

Performance

IBRN had a total return of 21.30% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.21%.